Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Joel M. Gelfand, MD, MSCE, FAAD

Joel M. Gelfand, MD, MSCE, FAAD Physician

Director, Psoriasis and Phototherapy Treatment Center Vice Chair of Clinical Research and Medical Director, Dermatology Clinical Studies Unit Professor of Epidemiology in Biostatistics and Epidemiology Professor of Dermatology

Dr. Gelfand is employed by Penn Medicine.

About Dr. Joel M. Gelfand

Recognized by Best Doctors in America, 2007-2019

Recognized in Philadelphia magazine's May 2019 Top Docs issue

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Dermatology

Programs & Centers:

Board Certification:

  • Dermatology, 2002

Clinical Expertise:

  • Acne
  • Acute Generalized Exanthematous Pustulosis
  • Allergic Contact Dermatitis
  • Atypical Mole
  • Basal Cell Carcinoma
  • Benign Neoplasm of Skin
  • Biologic Therapy for Skin Diseases
  • Chemical Peel
  • Contact Dermatitis
  • Cryosurgery of Skin Lesions
  • Dandruff
  • Dermatitis
  • Dermatographism
  • Destruction of Benign Skin Lesions
  • Destruction of Premalignant Skin Lesion
  • Dysplastic Nevus
  • Eczema
  • Electrosurgery for Skin Lesions
  • Erythroderma
  • Incision and Drainage
  • Laser Dermatology
  • Lichen Simplex
  • Mole Examination
  • Nevus
  • Non-Melanoma Skin Cancer
  • Parapsoriasis
  • Photodynamic Laser Therapy
  • Photodynamic Therapy (PDT)
  • Photosensitivity Reactions
  • Picker's Nodule
  • Pigmented Lesions
  • Pityriasis
  • Polymorphous Light Eruption
  • Port Wine Stain Treatment
  • Pre-Cancers of the Skin
  • Prurigo
  • Prurigo Nodularis
  • Pruritus
  • Psoriasis
  • Psoriasis Laser Treatment
  • PUVA Therapy
  • Rash
  • Scalp Psoriasis
  • Scaly Skin
  • Seborrheic Dermatitis
  • Seborrheic Eczema
  • Seborrheic Keratosis
  • Skin Biopsy
  • Skin Cancer
  • Skin Cancer Screening
  • Skin Cancer Surgery
  • Skin Examination
  • Skin Patch Tests
  • Squamous Cell Carcinoma of the Skin
  • Ultraviolet Therapy
  • Vitiligo
Show All Expertise

Practice Locations and Appointments

  • Penn Dermatology Perelman

    Perelman Center for Advanced Medicine South Pavilion, 1st Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-7366 (PENN)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oscar Health Plan of PA
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Harvard University
Residency: Mount Sinai Hospital
Residency: Hospital of the University of Pennsylvania


Advisory Committee Boston University's NIAMS Multidisciplinary Clinical Research Center (P60), National American Academy of Dermatology, National American Board of Dermatology, National American Dermatological Association, National American Society for Clinical Investigation, National BIMEKIZUMAB PHASE 3 PSORIASIS PROGRAM DATA MONITORING COMMITTEE, International Cancer Center, University of Pennsylvania, Local Data Safety Monitoring Board, UCB, Phase III Bimekizumab Program, International Dermatology Foundation, National Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, International Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, International Institute for Translational Medicine and Therapeutics,, Local International Psoriasis Council, International International Society for Pharmacoepidemiology, International Massachusetts Medical Society, National Medical Dermatology Society, National National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National National Multiple Sclerosis Society Serially Unified Multicenter Multiple Sclerosis Investigation (SUMMIT), National National Psoriasis Foundation, National NIAMS Ad hoc AMSC study section member, National NIH/NIAMS Selected Member Roundtable about Psoriatic Arthritis, National Penn Center for Orphan Disease Research and Therapy, National PENN Institute for Immunology, Local Pennsylvania Academy of Dermatology and Dermatologic Surgery, Local Scientific Advisory Committee (Elected) Psolar registry (sponsor Jansen Biotech), International Society for Investigative Dermatology, National The Agency for Healthcare Research and Quality, National

Hospital Affiliation

Dr. Gelfand is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Selected Publications:

Yeung H, Wan J, Van Voorhees AS, Callis Duffin K, Kreuger GG, Kalb RE, Weisman JD, Sperber BR, Brod BA, Bebo F, Schleicher SM, Shin DB, Troxel AB, and Gelfand JM.: "Patient reported reasons for the discontinuation of commonly used treatments for moderate-to-severe psoriasis." Journal of American Academy of Dermatology 68 : 64-72,2013.

Mehta NN, Torigian DA, Gelfand, JM, Saboury, B, and Alavi A: Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography (PET)/Computed Tomography (CT) Journal of Visualized Experiments 63 : e3777,2012.

Azfar AS, Seminara NM, Shin DB, Troxel AB, Margolis DJ, and Gelfand JM: Increased Risk of Diabetes and Likelihood of Receiving Diabetes Treatment in Patients with Psoriasis Archives of Dermatology 18 : 1 - 6 ,2012.

Gelfand JM, Wan J, Callis Duffin, K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Bebo BF, Troxel AB, Shin DB, Steinemann JM, Goldfarb J, Yeung H, and Van Voorhees AS: Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice Setting Archives of Dermatology 148 (4): 487-94,2012.

Langan SM, Seminara, NM, Shin, DB, Troxel A, Kimmel SE, Mehta NN, Margolis DJ, and Gelfand JM: Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom Journal of Investigative Dermatology Advance Online Publication : 2011.

Mehta N, Yu YD, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, and Gelfand JM: Systemic and Vascular Inflammation in Patients with Moderate to Severe Psoriasis as measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT): A Pilot Study Archives of Dermatology 147 (9): 1031-1039,2011.

Dommasch, ED, Abuabara, K, Shin, DB, Nguyen, J, Troxel, AB, and Gelfand JM.: The Risk of Infection and Malignancy with Tumor Necrosis Factor Antagonists in Adult Patients with Psoriatic Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Journal of the American Academy of Dermatology 64 (6): 1035-1060,2011.

Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, and Gelfand JM: Patients with severe psoriasis are at increased risk of cardiovascular mortality: Cohort study using General Practice Research Database European Heart Journal 31 : 1000-06,2010.

Gelfand JM, Dommasch E, Shin DB, Azfar RS, Kurd SK, Wang X, and Troxel AB: The Risk of Stroke in Patients with Psoriasis Journal of Investigative Dermatology 129 : 2411-2418,2009.

Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, and Troxel AB: The risk of lymphoma in patients with psoriasis Journal of Investigative Dermatology 126 : 2194-2201,2006.

Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, and Rolstad T: Epidemiology of Psoriatic Arthritis in the United States Population Journal of the American Academy of Dermatology 53 : 573-7,2005.

Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, and Troxel AB: The risk of myocardial infarction in patients with psoriasis Journal of the American Medical Association 296 : 1735-1741,2006.

Academic Contact Info

Perelman Center for Advanced Medicine
7th Floor, South Tower
Suite 730

Philadelphia, PA 19104
Patient appointments: 800-789-7366 (PENN)

Related Links